Endo Pharmaceuticals $ENDP will be presenting Phase 2 Data for XIAFLEX on Saturday. The study evaluated the safety and efficacy of the XIAFLEX injection under investigation for the treatment of palmar Dupuytren�s disease nodules. The presentation will be made at the annual meeting of the American Society for Surgery of the Hand in Austin, TX.